Companies · Pharma

NightingaleSummer 2014Inactive

San Francisco · CA, USA · Pharma · founded 2014 · http://nightingaleapp.com

Diligence memoA one-page analyst read on Nightingale — recommendation, valuation, rhythm, risks.
Total raised · real
0
Rounds
Latest step-up
Top 85%
Sector rank · raised
Latest stage · inferred

Nightingale: limited disclosed financing to assess.

Synthesized from the figures below est. — every claim rests on a number shown on this page.

Where it sits in Pharma

Nightingale is one of 310 Pharma companies tracked from San Francisco, CA, USA, on record since 2014. By capital raised it ranks in the long tail (ahead of 16% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst

App for managing care of autistic students

Nightingale is the clinical decision support solution for evidence-based interventions. We're committed to ensuring that service providers for individuals with autism and related disorders are equipped to administer high quality, personalized treatment. According to the CDC, 1 in 68 children in the U.S. are now diagnosed with autism, contributing to an estimated 1.5 million Americans living with the condition. Although autism has no known cure or scientifically proven pharmaceutical treatment, its symptoms can be abated and maintained through rigorous evidence-based interventions like applied behavior analysis, speech-language pathology, and occupational therapy. Nightingale provides these practitioners with a suite of tools for HIPAA-compliant data collection,reporting, and analytics that can be customized to any curriculum and used in any setting. By equipping service providers with a convenient and user-friendly solution for data management and analytics, Nightingale frees up more of their time for creating high-quality curriculums and working with clients.

EducationHealth Techpharma
Find Nightingale online

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

No round amounts on record to chart.

Financing ladder & sequence gaps

No staged rounds to sequence.

Modeled valuation trajectory
Base estimate est.
Conservative case
Upside case
Modeled post-money

Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Financing rhythm
Avg between rounds
Capital velocity
On record since
First round
0
Rounds on file
How it compares to the market

Benchmarked against 310 companies in Pharma. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages)
This company
Sector median$6.4M
Modeled value — vs sector median (estimate, all stages)
This company
Sector median$62.5M

Raised more than 16% of sector peers (real $). Modeled value above 16% of peers (estimate).

Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
No rounds recorded.
Intelligence
Modeled next raise
Modeled next size est.
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Registry & provenance

Nightingale is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
1200 Pharma LLCPharmaSeries A$14.1M$13.2Msame sector
A28 Therapeutics, Inc.PharmaSeed$1.9M$31.7Msame sector
AbInitio BioPharmasame sector
Acanna Therapeutics, Inc.PharmaPre-Seed$1.0M$16.1Msame sector
Advanced Cardiac Therapeutics IncPharmaSeries C$64.1M$1.6Bsame sector
ADvantage Therapeutics, Inc.PharmaSeries A$19.0M$111.4Msame sector
AeroRx Therapeutics, Inc.PharmaSeries A$10.4M$30.7Msame sector
Affect Therapeutics, Inc.PharmaSeries B$24.6M$232.7Msame sector
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Autism Solutions, Inc.Other Health CareSeed$13.7M73%
Autism F.I.R.S.T., LLCOther Health CarePre-Seed$5.5M71%
Liyfe
Digital Nurse to Automate Symptom Assessment and Risk…
Pharma70%
Autism Diagnostic Technologies, Inc.HealthtechPre-Seed$1.0M69%
Mindset Health
Building AI therapeutics for physical health conditions like IBS.
Pharma68%
Mission Autism Clinics LlcHealthtechSeed$2.0M68%
Joon Health
Pediatric digital therapeutic for the +100M families in the US
Healthtech68%
Ascend Autism Group, LLCOther Health CareSeed$10.2M67%
Frequently asked
What does Nightingale do and where is it based?
Nightingale operates in the Pharma sector, based in San Francisco, CA, USA. App for managing care of autistic students
Explore related

See where Nightingale sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Nightingale, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.